Link Between Aging Pathways in Mice Uncovered
|
By LabMedica International staff writers Posted on 11 Feb 2009 |
Two earlier identified pathways associated with aging in mice are linked, according to new research. This finding supports what researchers have recently begun to suspect: that the age-related degeneration of tissues, organs, and even facial skin is an active, purposeful process instead of a gradual failure of tired cells.
Derailing or suppressing this molecular treachery, although still far in the future, may enable investigators to one day add years on human lives--or at least delay the appearance of that next wrinkle. "There is a genetic process that has to be on, and enforced, in order for aging to happen,” said Howard Chang, M.D., Ph.D., associate professor of dermatology at the Stanford University School of Medicine (CA, USA; http://med.stanford.edu) and a member of Stanford's Cancer Center. "It's possible that those rare individuals who live beyond 100 years have a less-efficient version of this master pathway, just as children with progeria--a genetic aging disease--may have components of this pathway that are more active.”
The study, which was published in the January 9, 2009, issue of the journal Cell, came out of a three-year collaboration between Dr. Chang and Katrin Chua, M.D., Ph.D., assistant professor of endocrinology, gerontology, and metabolism at Stanford and a member of the Stanford Cancer Center. Drs. Chang and Chua are co-senior authors of the research.
The researchers focused their investigation on two seemingly separate pathways connected to aging. One involved a molecule known as SIRT6--a member of the sirtuin family of proteins that modulate life span in organisms such as yeast and worms--that Dr. Chua's laboratory has been studying for several years. She and her lab members have previously shown that SIRT6 is involved in genomic stability and the protection of chromosomal ends called telomeres. Telomeres, which grow shorter with each cell division, are thought to function as a sort of internal molecular clock associated with aging. Furthermore, mice lacking SIRT6 are born normally but die within a few weeks because of a rapid, multi-organ degeneration that somewhat resembles premature aging.
"Sirtuin family members have been implicated in aging and age-related diseases,” said Dr. Chua, "but very little was known about how SIRT6 worked on a molecular level until recently. Our new study reveals that SIRT6, in addition to its role in genomic stability and telomere protection, also regulates gene expression.”
The other pathway involved a better-known protein called NF-kappa B (NF-kB), which binds to and regulates the expression of many genes, including those involved in aging. The expression of many of these genes increases with age, and blocking the activity of NF-kB in the skin cells of elderly mice causes them to look and act like younger cells.
The researchers speculated if NF-kB and SIRT6 somehow work together to help cells age properly. They discovered that, in human and mouse cells, SIRT6 binds to a subunit of NF-kB and modifies components of a nearby DNA packaging hub, called histones. This modification makes it more difficult for NF-kB to trigger the expression of the downstream gene--possibly by causing the DNA to twist in such a way to kick off the protein.
"It seems that an important job of SIRT6 is to restrain NF-kB and limit the expression of genes associated with aging,” said Dr. Chang. "We've been interested in the activity of regulatory genes such as NF-kB during aging for several years now, and we were quite happy to find this very clear biochemical connection between these two pathways.”
Young mice lacking the SIRT6 protein displayed elevated levels of NF-kB-dependent genes involved in immune response, cell signaling, and metabolism--all potentially involved in the uniformly fatal aging-like condition that killed them within four weeks of birth. Suppressing the expression of the gene for NF-kB's SIRT-binding subunit allowed some of the mice to escape this fate.
"Mice lacking SIRT6 seem to hit some kind of a wall at around four weeks of age,” said Dr. Chua, "when their blood sugar drops to a level barely compatible with life. Reducing NF-kB activity somehow allows the mice to get over this critical period and to live much longer. These mice provide a great new tool to study the effect of SIRT6-deficiency in much older animals than was possible before.”
The researchers are now working to understand how NF-kB knows when and to what extent during an organism's lifetime to initiate the degenerative process and what role SIRT6 may play. "It's a very provocative question,” said Dr. Chang. "We've tied together two previously separate pathways in aging. Now we'd like to better understand what regulates that pathway.”
Related Links:
Stanford University School of Medicine
Derailing or suppressing this molecular treachery, although still far in the future, may enable investigators to one day add years on human lives--or at least delay the appearance of that next wrinkle. "There is a genetic process that has to be on, and enforced, in order for aging to happen,” said Howard Chang, M.D., Ph.D., associate professor of dermatology at the Stanford University School of Medicine (CA, USA; http://med.stanford.edu) and a member of Stanford's Cancer Center. "It's possible that those rare individuals who live beyond 100 years have a less-efficient version of this master pathway, just as children with progeria--a genetic aging disease--may have components of this pathway that are more active.”
The study, which was published in the January 9, 2009, issue of the journal Cell, came out of a three-year collaboration between Dr. Chang and Katrin Chua, M.D., Ph.D., assistant professor of endocrinology, gerontology, and metabolism at Stanford and a member of the Stanford Cancer Center. Drs. Chang and Chua are co-senior authors of the research.
The researchers focused their investigation on two seemingly separate pathways connected to aging. One involved a molecule known as SIRT6--a member of the sirtuin family of proteins that modulate life span in organisms such as yeast and worms--that Dr. Chua's laboratory has been studying for several years. She and her lab members have previously shown that SIRT6 is involved in genomic stability and the protection of chromosomal ends called telomeres. Telomeres, which grow shorter with each cell division, are thought to function as a sort of internal molecular clock associated with aging. Furthermore, mice lacking SIRT6 are born normally but die within a few weeks because of a rapid, multi-organ degeneration that somewhat resembles premature aging.
"Sirtuin family members have been implicated in aging and age-related diseases,” said Dr. Chua, "but very little was known about how SIRT6 worked on a molecular level until recently. Our new study reveals that SIRT6, in addition to its role in genomic stability and telomere protection, also regulates gene expression.”
The other pathway involved a better-known protein called NF-kappa B (NF-kB), which binds to and regulates the expression of many genes, including those involved in aging. The expression of many of these genes increases with age, and blocking the activity of NF-kB in the skin cells of elderly mice causes them to look and act like younger cells.
The researchers speculated if NF-kB and SIRT6 somehow work together to help cells age properly. They discovered that, in human and mouse cells, SIRT6 binds to a subunit of NF-kB and modifies components of a nearby DNA packaging hub, called histones. This modification makes it more difficult for NF-kB to trigger the expression of the downstream gene--possibly by causing the DNA to twist in such a way to kick off the protein.
"It seems that an important job of SIRT6 is to restrain NF-kB and limit the expression of genes associated with aging,” said Dr. Chang. "We've been interested in the activity of regulatory genes such as NF-kB during aging for several years now, and we were quite happy to find this very clear biochemical connection between these two pathways.”
Young mice lacking the SIRT6 protein displayed elevated levels of NF-kB-dependent genes involved in immune response, cell signaling, and metabolism--all potentially involved in the uniformly fatal aging-like condition that killed them within four weeks of birth. Suppressing the expression of the gene for NF-kB's SIRT-binding subunit allowed some of the mice to escape this fate.
"Mice lacking SIRT6 seem to hit some kind of a wall at around four weeks of age,” said Dr. Chua, "when their blood sugar drops to a level barely compatible with life. Reducing NF-kB activity somehow allows the mice to get over this critical period and to live much longer. These mice provide a great new tool to study the effect of SIRT6-deficiency in much older animals than was possible before.”
The researchers are now working to understand how NF-kB knows when and to what extent during an organism's lifetime to initiate the degenerative process and what role SIRT6 may play. "It's a very provocative question,” said Dr. Chang. "We've tied together two previously separate pathways in aging. Now we'd like to better understand what regulates that pathway.”
Related Links:
Stanford University School of Medicine
Latest BioResearch News
- BRCA2 Variant Analysis Offers Insights Into Breast Cancer Risk and Treatment
- Statistical Model Helps Track T Cell Behavior During Cancer Immunotherapy
- Blood NAD Levels May Offer Clues to Cardiovascular Health
- Organ-on-Chip System Offers Insights Into Tumor Interactions and Treatment Response
- Multiplexed Single-Cell DNA Methylation Workflow Enables Analysis of Blood Disorders
- Extracellular Vesicle Biomarkers Reveal Shared Signals in Aging and Cancer
- Study Reveals Regulatory DNA Element Involved in Breast Cancer Growth Suppression
- New ddPCR Assays Broaden Options for Multiplex Cancer Mutation Research
- Platelet Biomarkers Identify Progression Signals in Parkinson's Disease
- Molecular Atlas Offers New Framework for Breast Cancer Risk and Treatment Research
- New Method Isolates Neuron-Linked Vesicles From Blood and Cerebrospinal Fluid
- Lung Tumor RNA Variants Offer Clues to Immunotherapy Benefit
- Population-Scale Genome Survey Supports Interpretation of Genetic Testing
- Single-Cell Profiling Reveals Chemotherapy Resistance Signals in Ovarian Cancer
- Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders
- CSF Biomarker Meprin-Beta Increases in Alzheimer’s Disease
Channels
Clinical Chemistry
view channelAI and Nanotechnology Enable Five-Minute Urine Drug Screening
Rapid screening for illicit drugs remains challenging when testing must be performed at the point of care. Laboratory methods provide accurate results but require sample preparation and specialized equipment,... Read more
Study Questions Uniform Stool-Test Cutoff Across Age Groups
Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read moreMolecular Diagnostics
view channel
Blood RNA Patterns Linked to CAR T-Cell Response and Survival in Lymphoma
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, which involves engineering a patient’s own immune cells to recognize and attack cancer cells, has transformed treatment for large B-cell lymphoma,... Read moreGenome Sequencing Provides Clues to Unexplained Recurrent Miscarriages
Recurrent pregnancy loss, defined as two or more miscarriages, affects about 5% of couples. In many cases, routine evaluation does not identify a cause, particularly when pregnancies have a normal chromosome... Read moreHematology
view channel
Werfen Gains FDA Clearance for ROTEM sigma Cartridge Use in Trauma
Traumatic injuries account for approximately 10% of deaths worldwide, with uncontrolled bleeding remaining a leading cause of potentially preventable trauma-related death. Trauma-induced coagulopathy further... Read more
Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
Acute myeloid leukemia (AML) is an aggressive blood cancer affecting approximately 2,700 people in the U.K. annually, with only about one in six patients surviving five years after diagnosis.... Read moreImmunology
view channel
Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice
Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis
Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more
Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read moreMicrobiology
view channel
WHO Survey Reveals Gaps in Antimicrobial Resistance Testing and Response
Antimicrobial resistance (AMR) remains a major challenge for health systems, limiting effective treatment options for drug-resistant infections. These infections caused more than 1 million deaths and contributed... Read more
Direct-From-Specimen Pneumonia Test Detects Pathogens and Resistance in Hours
Pneumonia is a leading cause of sepsis and is associated with high mortality. Conventional culture-based pathogen identification and antimicrobial susceptibility testing can take two to four days, delaying... Read morePathology
view channel
Researchers Evaluate Automated Tissue Analysis Across Four Cancer Types
Histopathology image analysis plays a central role in cancer diagnosis, but tumor tissue can vary considerably across different regions of the same specimen. Pathologists examine cellular morphology, nuclear... Read more
AI Prostate Cancer Test Added to NCCN Guidelines for Post-Surgery Recurrence
Following radical prostatectomy, an estimated 20% to 40% of prostate cancer patients develop biochemical recurrence, marked by rising prostate-specific antigen levels that may indicate cancer recurrence.... Read more
New Training Approach Helps AI Distinguish Neighboring Cells in Tissue
Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Review Highlights Progress and Validation Needs for AI in Digital Pathology
Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read moreTechnology
view channel
Experimental Blood Test Detects Markers of Three Cancers and Alzheimer’s Disease
Colorectal cancer, glioblastoma, pancreatic cancer, and Alzheimer’s disease are serious conditions in which earlier detection may improve clinical outcomes. Blood-based testing could help identify dis... Read more
New qPCR Master Mixes Offer Broad Compatibility for Routine Research
Quantitative PCR (qPCR) workflows require consistent reagent performance across instruments and assay formats. Laboratories must also manage costs without changing established protocols.... Read moreIndustry
view channel
Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil
Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more







